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Abstract
Background: Unconjugated bilirubin (UCB) is an unstable substance with very low aqueous solubility. Its aqueous pKa 
values affect many of its interactions, particularly their pH-dependence. A companion paper shows that only our prior 
solvent partition studies, leading to pKa values of 8.12 and 8.44, met all essential requirements for valid pKa 
determinations. Other published values, generally lower, some below 5.0, were shown to be invalid. The present work 
was designed to derive suitable models for interpreting published data on the pH-dependent binding of UCB with four 
agents, mentioned below, chosen because they are not, themselves, sensitive to changes in the pH range 4-10, and the 
data, mainly spectrometric, were of reasonable quality.
Results: These analyses indicated that the high pKa values, dianion dimerization constant and solubilities of UCB at 
various pH values, derived from our partition studies, along with literature-derived pH- and time-dependent 
supersaturation effects, were essential for constructing useful models that showed good qualitative, and sometimes 
quantitative, fits with the data. In contrast, published pKa values below 5.0 were highly incompatible with the data for 
all systems considered. The primary species of bound UCB in our models were: undissociated diacid for 
phosphatidylcholine, dianion for dodecyl maltoside micelles and cyclodextrins, and both monoanions and dianion for 
sodium taurocholate. The resulting binding versus pH profiles differed strikingly from each other.
Conclusions: The insights derived from these analyses should be helpful to explore and interpret UCB binding to more 
complex, pH-sensitive, physiological moieties, such as proteins or membranes, in order to understand its functions.
Background
The true pKa values of unconjugated bilirubin (UCB) are 
an important determinant of the proportion of the three ion-
ization species of UCB in present in solution, and of the 
overall aqueous solubility of UCB, at any given pH value 
[1]. In a companion paper [2] we re-examined many pub-
lished studies that assessed pKa values for UCB in simple 
solutions, determined by a wide variety of methods. We 
critically assessed the reliability of the methods used, in 
relationship to minimal criteria for validity, as well as other 
considerations. We summarized the deficiencies in the 
many reports which suggested that pKa values of UCB 
were below 7.0 and even below 5.0 (see Table eight in Boi-
adjiev et al. [3]). The only experiments which fulfilled all 
the validity criteria were our solvent partition data [4,5], 
which indicated that the two pKa values were much higher, 
8.12 and 8.44.
pKa values of UCB are clearly of great importance in deter-
mining the effects of pH on the interactions of UCB with 
other molecules [1]. In the present paper, we critically re-
examine and reinterpret several reports dealing with the 
effects of varied pH on the interactions of UCB with phos-
pholipid vesicles, cyclodextrins, and dodecylmaltoside and 
bile salt micelles. Some general approaches have been 
developed to deal with the binding equilibria involved. We 
show that these studies are incompatible with proposed low 
aqueous pKa values for UCB. In several cases, the reinter-
pretations, using high pKa's and incorporating the effects of 
binding ratios, self-association and pH-dependent supersat-
uration, lead to some interesting new models and findings.
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Methods
Criteria for Acceptability and Pitfalls in Interpretation
Studies of UCB binding vs. pH should meet the same crite-
ria of validity proposed in the companion paper that deals 
with UCB alone in simple systems [2]: 1) The UCB is pure; 
2) There should be no significant degradation of UCB; 3) 
Measurements are made after a rapidly achieved equilib-
rium; 4) Unbound UCB concentrations are below to mini-
mally above aqueous saturation; 5) The pH range studied 
should encompass all suggested pKa values of UCB, and 
sufficient data points should be available to permit mathe-
matical modeling.
In addition, for studies of the effects of pH on UCB bind-
ing: 6) The large molecule or components of the aggregate 
must also be purified; 7) Changes with pH in the ionization 
and/or conformation of constituent regions of the large mol-
ecule or aggregate must not affect its intrinsic affinity for 
each UCB species. This last criterion renders it difficult to 
perform detailed mathematical modeling of pH effects on 
interactions of UCB with proteins, natural membranes and 
other biologically-relevant systems, which are often impure 
and include molecules whose conformation and binding 
properties for UCB are affected by pH in incompletely 
known ways.
Further discussion is needed regarding criterion 4, above, 
including the thermodynamic solubility of UCB crystals 
[4], and the possibility of stable supersaturation [6,7]. Brod-
ersen & Theilgaard [7], showed that, after extensive sedi-
mentation at 100,000 xg, the UCB concentrations were 0.1 
μM at pH 7.40, 0.5 μM at pH 7.83, 17 μM at pH 8.05, and 
34 μM at pH 8.2. Solubility calculated from our partition 
data [4] was 0.062 μM at pH 7.40, in reasonable agreement 
with the data of Brodersen's & Theilgaard [7], but our pari-
tion-derived solubilities at the higher pH values were con-
siderably lower than theirs: 0.084 μM at pH pH 7.83, 0.112 
μM at pH 8.05, and 0.148 μM at pH 8.2. Thus, for reasons 
discussed previously [4,6,7], stable supersaturation with 
UCB, up to fairly high UCB concentrations, may be 
expected at pH values of 8.0 and above, particularly with 
the short time intervals between solution preparation and 
data gathering in most spectroscopic studies. At modestly 
high concentrations of UCB, such supersaturation may 
actually be promoted by amphipathic additives, for exam-
ple bile salts [8,9]. In the reinterpretations attempted below, 
we have made comparisons of results expected in the pres-
ence and absence of supersaturation and assuming high vs. 
low pKa values for UCB.
Selection of Publications for Further Analysis
To find papers for possible review, we electronically 
searched PubMed (1967-date), and ISI and Chemical 
Abstracts databases back to 1950, using the keywords "bili-
rubin, bile pigments, binding, hydrogen-ion concentration, 
pH, pKa, ionization", as well as the reference lists in papers 
thus discovered. To locate papers published earlier than 
1968, we manually searched T.K. With's two comprehen-
sive compendia of studies related to bilirubin [10,11]. After 
eliminating papers that dealt only with bile pigments other 
than biladienes, or with bilirubin ester conjugates, papers 
were then eliminated that failed to meet the majority of the 
criteria of validity summarized above. In line with validity 
criterion 7, above, we then focused on studies of interac-
tions of UCB with host systems not expected to be sensitive 
to pH in the range of 5.5 to 10. These 12 papers and one 
abstract are summarized in Additional files 1, 2 and 3 
(Tables S1, S2 & S3), which specify experimental deficien-
cies for each study. Finally, we confined our detailed analy-
ses to the four best studies; binding of UCB to 
phosphatidylcholine (PC) [12], dodecylmaltoside micelles 
[13], β-cyclodextrins [14], and sodium taurocholate [15].
Results and Discussion
Ionization and Binding Equilibria of Unbound UCB Species
The equilibria governing the binding of unconjugated bili-
rubin (UCB) involve its three unbound species, the proto-
nated diacid (H2B), the monoanions (HB-) and the dianion 
(B=), one or more of which binds independently to a larger 
host system [1], such as phospholipid vesicles, cyclodex-
trins, or micelles. For each UCB species, this binding can 
then be described in terms of a distribution ratio, K = mols 
bound/mols unbound (free).
The ionization equilibria of the unbound species apply 
whether or not a binder is present. Thus, with a binder pres-
ent, at any pH, the relative fraction (f) of each unbound 
monomeric species of UCB (fH2B, fHB-, and fB=) will be 
equal to f for that species, at the same pH, in an aqueous 
phase containing only monomeric UCB species [1]. There-
fore, as described in the appendix in Hahm et al. [4], these 
unbound fractions are determined solely by the pH and the 
assumed pKa values of the monomeric species. The total 
concentration of unbound, monomeric UCB species (Bm) 
is given by Bm = [H2B] + [HB-] + [B=] = [H2B] × (1 + K1/
[H+] + K1.K2/[H+]2). Note that these illustrative calculations 
and simulations (Figures 1, 2 and 3 and Table 1) deal only 
with pH effects on monomeric UCB species, so that fH2B + 
fHB- + fB= = 1.00. Additional effects of the formation of B= 
dimers [4] and supersaturation [7,9,16] have been consid-
ered below in the actual fitting of experimental data on 
UCB binding to phospholipid vesicles, cyclodextrins and 
micelles (Figures 4, 5 and 6 and Table 2).
Figure 1 shows the fractions of UCB species over the pH 
range of 4 to 10, using the high pKa values of 8.12 and 8.44 
[4]. Table 1 shows the fractions derived by applying the low 
pKa values of 4.2 and 4.9, advocated in recent papers [3,17-
20]. For such low pKa values, B= is the dominant fraction at 
pH values above 7.0 (fB= ≥ 0.992, close to unity), with 
fH2B < 0.001 at pH values above 6.0 and fHB- < 0.001 at Mukerjee and Ostrow BMC Biochemistry 2010, 11:16
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pH values above 8.0. In stark contrast, for pKa values 
above 8.0 [4], the f values of H2B, HB- and B= are moder-
ately high over wide ranges of pH and are of comparable 
magnitude at most pH values between 6 and 10 (Figure 1). 
At pH ≤ 6.0, only fH2B is above 0.99 and, over the pH 
range of 6.5 to 10.0, significant roles can be played by any 
of the three UCB species, each of which will show signifi-
cant dependence on pH (Figure 1). The inescapable qualita-
tive conclusion from these considerations is that numerous 
studies which show UCB interactions increasing with pH in 
range of 6.5-10.0 are far more compatible with the high 
pKa values of UCB (> 8.0) than the low ones (< 5.0).
General Effects of Binding Affinities and pKa Values on 
Binding Curves
The values of pKa affect some characteristic features of the 
uptake and binding curves of UCB as a function of pH. As 
the pH increases, the equilibrium among the unbound spe-
cies of UCB will shift to the more ionized forms (Figure 1, 
Table 1). The binding of UCB will, therefore, increase with 
pH if the preferentially bound species is B= (as proposed for 
sodium taurocholate micelles [1,21]), but will decrease with 
pH if H2B is preferentially bound (as proposed for PC vesi-
cles [4,12]).
Figure 1 Fractions (f) of unbound monomeric UCB at various pH 
values. Calculated assuming high pKa values for UCB of 8.12 and 8.44 
[4]. Abbreviations: H2B, UCB diacid; HB-, UCB monoanions; B=, UCB dian-
ion. fH2B + fHB- + fB= = 1.
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Figure 2 Fraction of total UCB bound (F) at various pH values, as-
suming preferential binding of H2B: Effect of distribution ratio (K 
= bound/free UCB). Calculated assuming high pKa values for UCB of 
8.12 and 8.44 [4]. H2B, fully protonated UCB diacid; shaded star, mid-
point pH of titration curve.
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Figure 3 Fraction of total UCB bound (F) at various pH values, as-
suming preferential binding of B=: effect of distribution ratio (K' = 
bound/free UCB). Calculated assuming high pKa values for UCB of 
8.12 and 8.44 [4]. B=, UCB dianion; shaded star, midpoint pH of titration 
curve; open star, midpoint for TC binding (K' for B= = 730, [21]).
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Figure 4 Modeling UCB binding to phosphatidylcholine vesicles 
at various pH values. Experimental data derived from Tipping et al., 
1979 [12]. Curve A, calculated assuming pKa values for UCB of 8.12 and 
8.44 and the dimerization constant for the B= dianion of 0.26 μM-1 [4]. 
Curve B, calculated assuming constant maximum solubility of H2B of 
51 nM [4]. Curve C, calculated assuming pKa values of UCB of 4.2 and 
4.9 [3,17-20]. Shaded star, mid-point pH of binding curve A.
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The mid-point pH values of plots of binding vs. pH may 
shift significantly from the pKa of the unbound UCB ligand 
according to its affinity for the large molecule or aggregate, 
especially if the binding affinity for one of the three UCB 
species, H2B, HB- and B=, is strongly dominant. This effect 
is easily modeled by assuming that only one of the three 
species is bound and that the unbound UCB concentrations 
are low enough for self-association of the unbound UCB 
species to be negligible. The proportions of the unbound 
species, H2B, HB- and B=, are determined by the pKa values 
and the pH and calculated from the relevant terms in the 
model equation [4], as described above. If the relevant UCB 
species is not the only one bound, but is the predominant 
bound species, these analyses still apply qualitatively and 
the plots will closely resemble those derived by assuming 
that only a single UCB species binds.
Figures 2 and 3 show some simple representations of such 
modeling, using the high pKa values of 8.12 and 8.44 [4]; 
the fraction F = [UCB]bound/[UCB]total is plotted against pH. 
For Figure 2, it is assumed that only H2B binds, e.g. to a 
phospholipid vesicle [12]. The fraction F is calculated for 
values of the partition ratio K = [H2B]bound/[H2B]free, 
increasing from 0.2 to 104. As expected (Figure 2), with 
increasing pH, F decreases sigmoidally due to the decreas-
ing fraction (fH2B) of the unbound UCB diacid (Figure 1). 
For each curve, its mid-point pH, where the binding of H2B 
is 50% of the maximum, is represented in Figure 2 by a 
shaded star. These mid-point pH values increase from 8.255 
for K = 1, to 8.780 for K = 10, 9.251 for K = 102 and 9.778 
for K = 103; for very low K values <<1 (e.g. for K = 0.2), 
the limiting mid-point pH is 7.994. This increase in the 
mid-point pH of the binding curves of H2B with increasing 
K is a general result that applies to binding to any large 
molecule and to any pKa values that are chosen. An exam-
ple is binding of UCB to PC (Figure 4, curve A)
When the UCB dianion, B=, is the only interacting species, 
the uptake or binding is expected to increase with pH (Fig-
ure 3), due to the increasing fraction (fB=) of the unbound 
UCB dianion (Figure 1). Figure 3 plots F vs. pH at values of 
K' (= [B=]bound/[B=]free) of 0.2, 1, 10, 102, 103 and 104, 
assuming the pKa values are 8.12 and 8.44. The mid-point 
pH values of these sigmoidal curves (shaded stars), where 
binding of B= is 50% of the maximum, decrease from 8.348 
for K' = 1, to 7.863 for K' = 10, 7.315 for K' = 102, 6.794 for 
K' = 103 and 6.287 for K' = 104. The limiting value of the 
mid-point pH, when K' values are <<1 (e.g. K = 0.2), is 
8.574. This trend of decreasing mid-point pH values with 
increasing K' is also a general result for binding of B= to any 
large molecule for any pKa values chosen.
Many curves of UCB interactions as a function of pH show 
binding increasing with increasing pH (Figure 5; Additional 
files 1, 2 and 3, Tables S1, S2 & S3), indicating a primary 
role for the binding of B= and dictating that the mid-point 
pH values must be lower than the true pKa values of 
unbound UCB (Figure 3). Therefore, the large number of 
these titration curves with mid-point pH values between 6 
and 8 are compatible with high pKa values of 8.12 and 8.44 
[4], and quite incompatible with pKa values below 5.0. If 
pKa values were low, e.g. 4.2 and 4.9 [3,17-20], curves 
Figure 5 UCB binding to β-cyclodextrin at various pH values. Ex-
perimental data (black squares) from Kano et al., 1995 [14]. Curve A, cal-
culated ellipticity assuming pKa values for UCB of 8.12 and 8.44, with B= 
dimers [4]. Curve B, calculated ellipticity assuming pKa values of UCB of 
4.2 and 4.9 [3,17-20]. Curve C, calculated ellipticity assuming constant 
maximum solubility of H2B of 51 nM [4].
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showing increasing binding of UCB with increasing pH 
and, therefore, binding of B=, would yield mid-point pH 
values lower than about 5.0.
The mid-point pH values of sigmoidal titration curves, like 
those in Figures 2 & 3, are sometimes misinterpreted as 
average pKa values. This is clearly wrong, since all of the 
curves in Figures 2 &3 assume the pKa values of unbound 
monomeric UCB to be 8.12 and 8.44.
UCB Binding to Phospholipid Vesicles (Additional file 1, 
Table S1)
Unilamellar vesicles of phosphatidylcholine (PC) are bilay-
ers with a hydrophobic core of the fatty acid polymethylene 
chains, and hydrophilic exterior and interior surfaces com-
posed of phosphryl-choline sidechains whose terminal -
N+(CH3)3 groups are on the surfaces [22]. In the pH range 4 
to 10, PC's are zwitterions, with both the amine and phos-
phoric acid groups fully ionized [23,24]; thus, changes in 
UCB binding to PC may be attributed to altered proportions 
Table 1: Fractions (f) of unbound UCB species at different pH values, assuming low pKa values of 4.2 and 4.9*.
pH fH2B† fHB
-†f B
=†
4.0 0.5847 0.3689 0.0464
4.5 0.2639 0.5265 0.2096
5.0 0.0656 0.4137 0.5208
5.5 9.96E-03 0.1988 0.7913
6.0 1.17E-03 0.0735 0.9253
6.5 1.23E-04 0.0245 0.9753
7.0 1.25E-05 7.88E-03 0.9921
7.5 1.26E-06 2.51E-03 0.9975
8.0 1.26E-07 7.94E-04 0.9992
8.5 1.26E-08 2.51E-04 0.9997
9.0 1.26E-09 7.94E-05 0.9999
9.5 1.26E-10 2.51E-05 0.99997
10.0 1.26E-10 7.94E-06 0.99999
* Calculated assuming pKa values of UCB of 4.2 and 4.9 [3,17-20].
† Bilirubin species: H2B, diacid; HB-, monoanions; B=, dianion.
Table 2: Circular dichroism (ellipticity, 103θ) of UCB in 50 mM sodium taurocholate solutions*
[UCB] Exptl. Calculated
pH μM 103θ† fsHB-‡f sB= ‡1 0 3θ†
7.23 34.0 -11.80 0.1661 0.5790 -13.42
7.35 4.6 -12.60 0.1474 0.6780 -11.06
8.13 4.6 0.69 0.0345 0.9550 1.50
8.15 34.0 1.90 0.0330 0.9570 1.66
9.12 4.6 5.10 0.0037 0.9946 4.75
9.35 34.0 5.38 0.00217 0.9962 4.91
11.60 34.0 5.50 0.000012 0.9986 5.13
* Data from D'Alagni M, et al., 1994 [15]. For experimental problems, see Additional file 3, Table S3.
† 103θ values obtained with 4.6 μM UCB have been multiplied by a factor, 34/4.6, to render them comparable with 103θ values obtained at 
34 μM UCB.
‡ fsHB- and fsB=, fractions of total UCB bound to TC as monoanion and dianion respectively, calculated utilizing the partition ratios of each 
UCB species in water [4] and 50 mM TC [21], plus fitted 103θ values for bound HB- and B=, derived from modeling the experimental changes 
in 103θ with pH, as described in the text.Mukerjee and Ostrow BMC Biochemistry 2010, 11:16
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of the three ionization states of unbound UCB in this pH 
range. Depending upon the molar ratios and experimental 
conditions under which the UCB and PC are mixed, either 
H2B or B= may be the UCB species that is preferentially 
bound [25].
pH effects on the interactions of UCB with PC vesicles 
have been reported in a number of studies [12,16,22,25-27]. 
Many of them involve time-dependent processes in non-
equilibrium situations. Some used PC systems containing 
fluorescent probes, which are difficult to interpret due to 
uncertainties regarding the localization of the probes and 
the nature of their interactions with UCB.
The report by Tipping et al. [12], which assessed binding of 
UCB to egg PC vesicles from the effects of binding on the 
spectrum of UCB, most fulfills the above criteria of an 
acceptable study (Additional file 1, Table S1), although nei-
ther the UCB (10 μM) nor the PC (100 μM) were purified. 
We have, therefore, amplified our previous analysis [4] of 
this study.
The data points in Figure 4 (black squares) show values of ñ 
(moles of UCB bound per mole of total PC) vs. pH over the 
pH range of 6.54 to 9.54, obtained from Figure 10 in the 
paper of Tipping et al. [12]. ñ decreases from a maximum 
of 0.049 as pH increases, indicating (see Figure 2) that the 
binding of H2B is the predominant interaction. The concen-
tration of bound UCB (Bb = ñ × 100 μM) is then used to 
calculate the concentration of unbound UCB (Bf = 10 μM - 
Bb). Bf ranges from 5.1 μM at pH 6.54 to 9.5 μM at pH 
9.54.
At each pH, the fraction of unbound H2B (= [H2B]f/Bt) in 
the presence of 100 μM PC [12], is assumed to be equal to 
the fraction of H2B ([H2B]/Bw) in the aqueous phase in the 
absence of PC, calculated using Equation four in Hahm et 
al. [4]) and applying the high pKa values of 8.12 and 8.44 
and the dimerization constant for the B= dianion of 0.26 
μM-1.
Assuming that unbound UCB is in a solution state and that 
H2B is the only species that binds to the PC yields a simple 
model of distribution of H2B between the free and vesicle-
bound state, ñ = K" [H2B]f. Applying this equation to the 9 
data points of Tipping et al. [12], yields a mean K" = 
0.00932 ± 0.00053 μM-1) and curve A in Figure 4). The fit 
of curve A with the experimental ñ values (black squares) is 
quite good (r = 0.953), and suggests that our assumptions 
are valid and that the H2B partition model is reasonable. 
The deviation of the data points from Curve A at the highest 
two pH values possibly reflects weak binding of the B= 
dianion [16,22,27], which constitutes over 80% of the UCB 
species above pH 9.0.
Tipping et al. [12] reported that "The spectral differences 
developed within the time required to mix the solutions and 
start recording and were the same whether multilamellar or 
unilamellar vesicles were used". This rapid analysis and 
establishment of equilibrium are necessary conditions for 
our detailed interpretation of the data. With the total con-
centrations of UCB = 10 μM and PC = 100 μM (molar ratio 
of UCB/PC, 0.1) used in the pH-variation study, the 
unbound UCB concentrations (Bf) at equilibrium were 
modestly above the aqueous solubility of UCB at all pH 
values ≤ 9.0 [4]. If supersaturation were absent, the concen-
tration of H2B would be at its saturation value over the 
entire pH range, and ñ should maintain its value of 0.049 at 
pH 6.54 (the horizontal dashed line B, in Figure 4). The 
experimental data indicate, therefore, that stable supersatu-
ration was indeed likely present in these short term experi-
ments.
If, by contrast, the low pKa values of 4.2 and 4.9 [3,17-20], 
are used to fit the ñ value at pH 6.54, a much higher value 
of K", 94 μM-1, is needed to yield the calculated [H2B]. 
Using this constant and [H2B], determined from Bf and the 
low pKa values, yields curve C in Figure 4. As pH increases 
from 6.5 to 7, ñ decreases steeply, and is below 0.01 at a pH 
of 6.9 or higher. The low pKa values are, thus, not compati-
ble with ñ vs. pH data determined for the binding of UCB 
by neutral PC vesicles [12]. Since, in this study, K ≈ 1 [12], 
the mid-point pH value of 8.1 (shaded star, Figure 4, curve 
A) would be close to the mid-point value of the curve for K 
= 1 in Figure 2, and thus compatible with our proposed high 
pKa values in the absence of a UCB binder [4].
Comments are warranted on an often-cited study, by Erik-
sen, et al., of the binding of UCB to egg PC vesicles [16]. 
The concentrations were 12.8 μM UCB and 130 μM PC. 
Figure two in that paper plots the changes with pH of the 
quenching by bound UCB of the fluorescence of diphenyl-
hexatriene incorporated into the lipid bilayer, measured 3 
hours after adding the UCB in an aqueous alkaline solution 
(pH 11). The sigmoidal curve exhibits decreasing fluores-
cence (increasing quenching by bound UCB) as pH 
increases, with a mid-point near pH 7.8. This evidence for 
increased affinity of UCB binding to PC as pH increases 
would indicate a primary role of binding of the dianion, B=. 
Since the dianion fraction for low pKa values is already 
0.992 at pH 7.0 (Table 1), any significant increase in bind-
ing at higher pH values is incompatible with low pH values 
(see above). The increasing affinity of UCB for PC with 
increasing pH is in stark contrast to Tipping's data [12] and 
to our model based on uptake of H2B (above). However, 
examination of data in Table one of the Eriksen paper, 
reveals that results obtained "immediately" after adding the 
UCB at pH 7.4 and 8.3 are just the reverse of those obtained 
three hours later (as in their Figure two).
Eriksen's Figure one [16] indicates complex, pH-dependent 
time effects. Using the percent decrease in fluorescence, P, 
as a rough measure of the extent of binding of UCB, the 
data show a high value of P = 79% at pH 7.43 "immedi-
ately" after addition of UCB. Within one minute, there is Mukerjee and Ostrow BMC Biochemistry 2010, 11:16
http://www.biomedcentral.com/1471-2091/11/16
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rapid reversal of binding and P is decreased to 28%, fol-
lowed by a far less rapid decrease in P to 23% after 3 hours. 
Results at pH 6.79 are similar. In contrast, at the highest pH 
in their Figure one, 8.34, the "immediate" value of P = 57% 
remains about the same for three hours. At the intermediate 
pH of 7.90, the "immediate" value of P = 73% increases a 
little over the first minute, remains about the same for four 
more minutes, and then decreases gently over the next two 
hours or so to a plateau of P = 22%. These complex time 
effects yield very different sequences of P values decreas-
ing with pH: 7.43>7.90>8.34 for "immediate" measure-
ments; the irregular sequence 7.90>8.34>7.43 between 1 
and 20 minutes; 8.43>7.90>7.43 at 60 minutes; and 
8.34>7.90 ≈ 7.43 at 3 hours. Some discrepancies among 
data in Eriksen's Table one, Figure one and Figure two [16], 
suggest irreproducible time effects.
These observations can be rationalized roughly on the basis 
of the progressive formation of aggregates of UCB, after 
the initial rapid binding of UCB. Cestaro et al. [22] have 
made a similar proposal, and Eriksen et al. [16] themselves 
warn that, as the pH falls, supersaturation of the aqueous 
medium with UCB must be avoided to prevent progressive 
formation of H2B aggregates. Their gradient ultracentrifu-
gation data of 3 hour incubations (Figures three-d&e of 
Eriksen et al.) [16] showed large aggregates of UCB, with 
or without phospholipids, at pH 7.0 and smaller aggregates 
at pH 8.2. The dependence on pH, of the rates of formation 
of colloids and precipitates from supersaturated solutions of 
UCB itself, is clearly relevant. As discussed earlier, after 
extensive sedimentation at 100,000 xg, the measured super-
natant concentrations of UCB at pH values of 7.40, 7.83, 
8.05 and 8.2 were 0.1 μM, 0.5 μM, 17 μM and 34 μM 
respectively [7]. These are much higher than the calculated 
solubilities of UCB at the same pH values [4], which were 
low (0.062 μM, 0.084 μM, 0.112 μM and 0.148 μM) and 
increased only a little as pH increased. This indicates that 
the egg PC-UCB systems of Eriksen et al. [16] were highly 
supersaturated when first prepared, and that aggregates of 
UCB formed to relieve the supersaturation. This occurred 
to a much greater extent and much more rapidly at pH 7.43 
than at pH 8.34, with intermediate behavior at pH 7.90. Any 
micro-precipitation of UCB, which may contain small pro-
portions of PC, will reduce Bf and its interactions with PC 
vesicles. Vazquez et al. [28] have also reported significant 
reversal of UCB interaction with phospholipid membranes 
with time.
In view of the above considerations, and evidence that the 
uptake of UCB by PC vesicles is almost instantaneous (t1/2 
= 2 msec) [29], we conclude that the "immediate" effects on 
P after addition of UCB to PC are least susceptible to time-
dependent effects arising from the thermodynamic drive to 
decrease supersaturation. Indeed, even the "immediate" val-
ues of P may still be subject to some aggregation effects, 
particularly at pH 7.43. The qualitative trend in the "imme-
diate" decrease of P with increasing pH is consistent with 
the results of Tipping et al. [12] and with our model, based 
on the binding of H2B and high pKa values for UCB. The 
conclusions are opposite to those given by Eriksen et al. 
[16], which were based on assumptions of binding of the 
dianion, B=, and low pKa values.
Other systems studied by Eriksen et al. [16] (their Table one 
and Figure one-b) also show exceptionally large and rapid 
decreases in binding of UCB with time at pH 7.4, interme-
diate behavior at pH 7.90, and minor effects at pH 8.34. 
These systems all contained 12.8 μM UCB, mixed with var-
ious types of phospholipids ± cholesterol, at varied concen-
trations: egg PC, 150 μM + cholesterol 15 μM; 
phosphatidlyethanolamine, 106 μM; phosphatidlyetha-
nolamine, 102 μM + cholesterol 10 μM; sphingomyelin, 32 
μM; and phosphatidylserine, 55 μM. The qualitative inter-
pretations above apply to all of them. The data points are 
limited, and some of these systems involve charge effects, 
which introduce further uncertainties. In all systems, after 3 
hours, UCB binding is greater at pH 8.3 than at pH 7.4. The 
"immediate" results, however, show a stronger reverse 
effect of pH, P = 82% at pH 7.4 vs. 25% at pH 8.3, for the 
egg PC-cholesterol system as compared to the egg PC sys-
tem. They also show lower binding to sphingomyelin at the 
higher pH, indicating predominant binding of H2B. This 
common pattern leads us to conclude that the complex pH-
dependence of precipitation of UCB from supersaturated 
solutions can lead to highly anomalous pH-dependence of 
UCB interactions with phospholipids.
The study of UCB binding to gangliosides by Vazquez et al. 
[30], reported little change in UCB binding going to pH 7.4 
to 8.0, but a small increase in going from pH 7.0 to 7.4, sug-
gesting an important role for UCB anions. Assuming low 
pKa values, the unbound dianion fraction changes only 
from 0.992 at pH 7.0 to 0.999 at pH 8.0, whereas the mono-
anion fraction decreases by a factor of 10 (Table 1). There-
fore, these observations are incompatible with low pKa 
values, whereas with high pKa values, both the mono- and 
dianon fractions increase significantly over this pH range 
(Figure 1). Other problems with this study (Additional file 
1, Table S1) are that: the systems were highly supersatu-
rated with UCB, the UCB was neither purified nor pro-
tected against degradation, equilibrium was not attained 
rapidly, and the pH range studied was insufficiently broad 
to derive pKa values.
Zucker and Gössling used stop-flow kinetics to examine the 
rates of uptake of BSA-bound UCB by cultured HepG2 
cells [26]. They found an inverse correlation between pH 
and the rate of UCB flip-flop, which they showed to be due 
to pH effects on the rates of dissociation of UCB from albu-
min and from the membrane bilayer. They concluded that 
"the identification of an inflection point at pH 8.1 is indica-
tive of a pKa value for bilirubin in this range". Although Mukerjee and Ostrow BMC Biochemistry 2010, 11:16
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this seemingly supports our contention that the pKa's of 
UCB are above 8.0 [4], these are kinetic and not equilib-
rium data, involve BSA (which is pH-sensitive in this 
range), and measure diffusion across a complex hepatocyte 
membrane. Studies of binding of UCB to whole cells [31], 
or natural membranes (e.g. red cell ghosts, mitochondria, 
synaptosomes) [28,32-35], likewise cannot be used to eval-
uate unequivocally the role of pKa values for UCB. These 
heterogeneous structures contain a mix of phospholipids, as 
well as proteins and other components, which may ionize 
and change conformation in the pH range studied and have 
unknown effects on membrane structure.
Interactions of UCB with Dodecyl Maltoside Micelles 
(Additional file 2, Table S2)
Non-ionic long-chain alkyl-saccharides, such as octylgluco-
side (C8G) or dodecylmaltoside (C12M), are readily purified 
and form micellar systems that are suitable for studies of 
the influence of pH on the uptake of UCB. Binding proba-
bly involves interactions of the -OH groups of the saccha-
ride with the ionized -COO- groups of UCB, and induces 
marked changes in the ellipticity of the bound UCB [13].
Kano et al. [13] showed that solubilization of UCB (20 μM) 
in 1 mM C12M micelles (their Figure five) generated no cir-
cular dichroism effects from pH 4.5 to 6.2. (Note that their 
legend for Figure five misidentifies the saccharide as C8M, 
octylmaltoside; the text indicates it is C12M that was stud-
ied.) Kano's Figure three shows that UCB does not interact 
with C8G below the c.m.c. of 22 mM. The same would be 
expected of C8M, whose c.m.c. value should be similarly 
high, but the concentration of the alkyl-saccharide used in 
their Figure five is 1 mM, well below the presumed c.m.c. 
of C8M.) Above pH 6.2, the observed ellipiticity increased 
steeply with rising pH up to about pH 8.5, and leveled off to 
a constant value from pH 8.8 to 10. Since the conformation 
of the non-ionic C12M is unaffected by pH, their titration 
curve reflects increased binding of UCB dianion (B=) as the 
proportion of unbound dianion, fB=, increases with increas-
ing pH.
The rise in ellipticity with pH has a mid-point of about pH 
7.5. Reference to our Figure 3 shows that this is compatible 
with high pKa values of 8.12 and 8.44 and a UCB distribu-
tion ratio K (bound/free) between 10 and 100. If the low 
pKa values of 4.2 and 4.9 are invoked, the midpoint pH 
value would have to be lower than about 5, as discussed 
above. Moreover, at pH 6.5, the fraction of UCB dianion, 
fB=, would already be 97.5%, yet the observed ellipticity is 
near zero at that pH. In addition, the steep rise in ellipticity 
observed above pH 6.5 would not be expected. Thus, only 
the higher pKa values are compatible with the observed 
data.
Interactions of UCB with Cyclodextrins (Additional file 2, 
Table S2)
Kano et al. [14] and Lightner et al. [36] studied CD of UCB 
in solutions of β-cyclodextrin (β-CDx) as a function of pH. 
Both studies used purified UCB and were conducted within 
minutes of mixing UCB with the cyclodextrins; Kano's 
studies also took precautions to minimize oxidation and 
photo-oxidation of the pigment. In each study, the molar 
circular dichroism absorption coefficient (Δε) was minimal 
at pH 6.0 and increased steeply as pH increased above pH 
7.0, indicating that UCB dianions are the primary interact-
ing species. Lightner's systems [36] were even more super-
saturated than Kano's and measurements were provided 
only at integral pH values from 6 to 10, rendering Kano's 
data [14] preferable for analysis.
In the study by Kano et al. of UCB binding to β-CDx [14], 
no ellipticity was observed at pH 5.5, but Δε increased sig-
moidally as pH increased from 5.5 to 9.5, with a steep slope 
between pH 7.0 and 8.5, and no further change between pH 
9.5 and 10.8 (their Figure 3). Chiral recognition effects, 
registered at several pH values with the protonated 1-
amino-β-cyclodextrin as the host molecule, (their Figure 
three [14]), support the conclusion that predominantly UCB 
dianion was bound.
At pH 10.8, an affinity constant of 23 L/mol was reported 
for UCB binding to β-CDx, indicating that 4.67 μM, or 
18.7% of the total [UCB] (25 μM), was bound to 10 mM β-
CDx at that pH. Assuming that the UCB binding is con-
fined to B=, and that binding of UCB is proportional to the 
concentration of unbound, monomeric B=, the amount of 
UCB bound at lower pH values can be calculated using Δε 
values relative to Δε at pH 10.8. It is then possible to calcu-
late Bf and, akin to modeling the data on binding of UCB to 
PC as described above, to apply Equation four of Hahm et 
al. [4] to calculate the unbound, monomeric dianion con-
centration, [B=], at each pH, assuming different pKa values.
Assuming the high pKa values of 8.12 and 8.44 and the 
dianion dimerization constant of 0.26 μM-1 [4] in calculat-
ing [B=]f from Bf, the four data points at pH values of 10.8, 
9.5, 8.65 and 8.2 showed an excellent proportionality 
between Δε and [B=] using the equation Δε = Q × [B=]f, 
where the constant, Q = 1.099 ± 0.018 (n = 4, r = 0.974, 
S.D. = 0.17). Curve A in Figure 5 shows the results of fit-
ting all the data to the above equation, Δε = 1.099 × [B=]. 
Curve A gives a reasonable fit for the experimental Δε at 
the five highest pH values (7.83 and above) and, of course, 
the very low pH of 5.5, where Δε = 0. Bf was below calcu-
lated solubilities at both pH 10.8 and 9.5, but there was 
likely stable supersaturation of the unbound UCB phase at 
the three lower pH values, based on previous observations 
[7], as discussed earlier. The rapid decrease in Δε below pH 
8.65 is primarily due to the rapid decrease in the fraction of 
unbound monomeric UCB that exists as the dianion (fB=). Mukerjee and Ostrow BMC Biochemistry 2010, 11:16
http://www.biomedcentral.com/1471-2091/11/16
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The systematic discrepancies between the data and Curve A 
in the pH range of 7.3 to 6.9 (Figure 5) can be ascribed to 
many factors that are difficult to evaluate, including self-
aggregation of the more highly supersaturated phase of 
unbound UCB (e.g. R = 369 at pH 7.0).
In comparison to the reasonable representation of the Δε 
data using pKa values above 8.0, the results obtained are 
very different (Figure 5, Curve B) if the lower pKa values 
of 4.2 and 4.9 [3,17-20], are used to calculate [B=] from Bf. 
The proportionality constant K, relating Δε to [B=] was 
determined by fitting the data at the pH values of 9.5 and 
10.8, where the solutions are undersaturated with unbound 
UCB. K was then used to calculate Δε from the estimated 
[B=] at other pH values. Since the dianion fraction (fB=) of 
unbound UCB would be close to unity at pH 7.0 or above, 
and have the value of 0.79 even at pH 5.5, little variation is 
expected in [B=] and, therefore, in Δε over the alkaline pH 
range. This is shown by Curve B in Figure 5, which does 
not fit Kano's Δε vs. pH data [14]. This indicates that the 
low pKa values are highly incompatible with the experi-
mental observations. The same conclusions apply to the 
data of Lightner et al. [36], which show similar pH depen-
dence of binding at alkaline pH.
From the mean fit of the Δε data at pH 9.5 and 10.8 to the 
concentrations of [B=] calculated using pKa values of 8.12 
and 8.44 and the dianion dimerization constant of 0.26 μM-
1, it is possible to calculate Δε from [B=] at lower pH val-
ues, where total solution concentrations are above solubil-
ity, by assuming that all solutions are at true saturation, with 
the excess [B=] forming a suspension. For such systems, 
[B=] = 0.051 × 10(2pH-16.56). Here, 0.051 μM is the solubility 
of H2B and 16.56 = pKa1 + pKa2 [4,6]. The calculated curve 
C (Figure 5) shows a steep drop in Δε below pH 9.3. Curve 
C has little resemblance to the experimental data, suggest-
ing that, at most pH values, a stable supersaturation was 
probably important in these relatively short-term experi-
ments.
Interactions of UCB with Bile Salts (Additional file 3, Table 
S3)
Taurine-amidates of bile salts, which have pKa values near 
1.0, are the only bile salts which are fully ionized through-
out the pH range from 4 to 10 [37], and are thus most suit-
able to assess the roles of pH and pKa values on UCB 
binding. Rapid solvent partition of purified UCB from 
undersaturated chloroform solutions into buffered aqueous 
solutions of 50 mM taurocholate (TC) (at least 80% in 
micelles), at ionic strength = 0.15, was performed over the 
pH range of 6.0 to 9.5 [1,21]. The data were fitted to the 
equation log P = log Po + [1 + 10(pH-A) + 10(2pH-B)], where 
Po is the partition ratio for H2B, and the values for A and B 
were 7.36 ± 0.5 and 14.08 ± 0.05 respectively.
Solubilities of UCB in 50 mM TC [21] and in water [4] 
were calculated from the fitted P data and an estimated sol-
ubility of UCB in chloroform of 1.14 mM [9]. (As argued 
before [4,6], a better estimate of the solubility of UCB in 
chloroform is 0.88 mM, which will decrease the estimated 
UCB solubilities in 50 mM TC and water by 23%, but not 
affect the shape of the titration curves.) Using the high 
aqueous pKa values of 8.12 and 8.44, the total and unbound 
concentrations of each UCB species in 50 mM TC was cal-
culated from the solubilities in 50 mM TC/chloroform [21] 
and water/chloroform [21] respectively; their difference 
equaled the concentration of the bound species. From these, 
the distribution ratios (bound/free) of the three UCB species 
were calculated to be 1.41 for H2B, 12.9 for HB-, and 730 
for B=, indicating predominant binding of B= [21], as con-
cluded previously by Kano et al. [38]. From the relative 
contributions of bound B=, HB- and H2B, the apparent pKa 
values of UCB associated with the TC were estimated: 7.16 
± 0.5 for pKa1, 6.69 ± 0.5 for pKa2 and 13.85 ± 0.05 for the 
sum of pKa1 and pKa2, which is derived with somewhat 
greater precision.
The relationship of these pKa values, lower than the aque-
ous values of 8.12 and 8.44, to micelle-water distribution 
ratios for H2B, HB- and B=, has been discussed in our com-
panion paper [2]. pKa values in the bile salt systems in the 
range of 6 to 7 have also been reported from studies using 
micellar electrokinetic capillary chromatography [39,40]. 
Since these authors did not determine micelle-water distri-
butions, these were average values for the whole system, 
but appear to be compatible with Hahm's pKa values in 50 
mM TC derived by solvent partition [21]. Utilizing essen-
tially the same equations [1,40] relating changes in pKa 
values resulting from uptake in micelles and micelle-water 
distribution ratios for H2B, HB- and B= mentioned above 
[21], the pKa values of 6 to 7 in 50 mM TC are thus com-
patible with the high pKa values in water [4].
CD studies have been performed with unpurified UCB in 
50 mM solutions of various bile salts [15,41,42]. In many 
cases, the UCB concentrations used appear to be above sat-
uration. For 50 mM sodium taurocholate (TC), calculated 
Bf was above aqueous phase saturation at pH below 7.5 
when total UCB was 4.6 μM and at pH below 8.3 when 
total UCB was 34 μM. Bile salts, however, have been 
shown to promote extensive, stable supersaturation of UCB 
[8,9]. In systems of UCB in 50 mM TC [15], the observed 
ellipticities were reasonably proportional to the two UCB 
concentrations, even though the calculated solubility in 50 
mM TC was exceeded at several pH values. Similar propor-
tionalities are seen over higher ranges of concentration of 
sodium glycocholate [15] and sodium deoxycholate [41] at 
pH values of 7.0 and above.
Since background information is available for 50 mM TC 
[21] and TC is expected to show no dependence upon pH, Mukerjee and Ostrow BMC Biochemistry 2010, 11:16
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we have attempted a semi-quantitative interpretation of the 
pH effects for the ellipticity study of 4.6 μM and 34 μM 
UCB in 50 mM TC [15]. We assumed stable supersatura-
tion in these short-term experiments (30 min or less) at pH 
values of 7.23 and higher. Table 2 presents ellipiticity val-
ues at 458 nm, estimated from their published graphs. The 
three measurements at 4.6 μM UCB have been multiplied 
by the factor, 34/4.6 to render them comparable to measure-
ments at 34 μM UCB. The ellipticities are large and nega-
tive at the two lowest pH values of 7.23 and 7.35, become 
positive at pH about 8.1, and then show higher positive val-
ues as pH increases to 9.1 and above. This general trend 
was exhibited by all the bile salts studied [15,41,42].
As noted earlier, equations relating partition coefficients to 
pH for 50 mM TC [21] and water [4] allow the calculation 
of the fractions of total UCB solubilized by the TC as H2B, 
HB- and B=. The pH-dependence of the ellipticity values at 
458 nm suggest strongly that the interactions with TC 
aggregates of the solubilized HB- cause negative elliptici-
ties whereas interactions of the solubilized B= cause posi-
tive ellipticities. Table 2 shows the estimated fractions of 
total UCB (34 μM) that are bound to TC as HB- and B=. As 
expected, as pH increases, the fraction of total UCB that is 
bound to TC as HB- (fs
HB
-) decreases and the fraction bound 
as B= (fs
B
=) increases. In order to test our model, we use the 
equation below in which the constants A* and B* are mea-
sures of the effectiveness of (fs
HB
-) and (fs
B
=) in determining 
the value of 103θ:
The experimental ellipticity values in Table 2 are well 
described by this equation: n = 7, r = 0.992, SD = 1.1, A* = 
-98.7 ± 5.6, B* = 5.24 ± 0.54. Figure 6 shows that, at total 
UCB concentrations of 4.6 and 34 μM, the experimental 
ellipticities are in reasonable concordance with calculated 
ellipticities. Note that the two most positive ellipticity val-
ues for 4.6 μM UCB, at pH 8.13 and 9.12, and for 34 μM 
UCB at 9.35 and 11.60 were measured in unsaturated solu-
tions. The significant changes in ellipticity at these high pH 
values are clearly due to significant changes in (fs
HB
-) and 
(fs
B
=) over this alkaline pH range. Remarkably, the mea-
sured ellipticity increased significantly, by about 2%, 
between pH 9.35 and 11.60, which is matched by a calcu-
lated increase in ellipticity of about 4%. Since, if low pKa 
values are assumed (Table 1), fB
= is already close to unity at 
pH 8.5 (0.9997), and the changes in ellipticity at pH values 
above 9.0 are qualitatively incompatible with the low pKa 
values for UCB proposed by others [3,17-20]. The model 
proposed here for representing the circular dichroism val-
ues of UCB in 50 mM TC appears to be new and is likely to 
be useful also for other bile salt systems.
Conclusions
The analyses and interpretations presented above show that 
the high pKa values of 8.12 and 8.44 [1,4-6] are far superior 
to low pKa values of 4.2 and 4.9 [3,17-20] in rationalizing 
experimental data for the effects of pH on interactions of 
UCB with PC vesicles, cyclodextrins, and micelles of dode-
cyl maltoside and bile salts. The approaches outlined also 
demonstrate and take into account the possibly important 
roles of self-association of B= and pH-dependent supersatu-
ration effects. They support further the conclusions of our 
companion paper [2] that analyzes the effects of pH on var-
ious properties of UCB alone in aqueous and organic sol-
vent systems. That paper demonstrated that only our 
solvent partition studies [4,5] met all the requirements for 
valid experiments when using a poorly-soluble, unstable 
compound, such as UCB. Together, the two present papers 
clearly indicate that the pKa values of UCB are well above 
the pKa values of simple carboxylic acids (usually about 
4.5). Theoretically these remarkably high values may result 
from the combined interactions of three factors that result 
from the unique, complex internal hydrogen-bonding of 
UCB, as presented elsewhere [5].
We do not claim that the high pKa values of 8.12 and 8.44, 
derived from our solvent partition study of UCB [4], are 
exact. The accuracy of these model-derived high pKa val-
ues of UCB is given on page 1131 of that paper. These val-
ues (mean ± S.D.) are: pK'1 = 8.12 ± 0.23; pK'1 + pK'2 = 
16.56 ± 0.10; pK'2 = 8.44 ± 0.33. That paper also notes that 
"the analysis yields a less accurate estimate of the individ-
ual pKa values than of their sum, pK1 + pK2". The errors in 
these pKa values are insignificant when compared with the 
difference of 7.5 pH units between the sum (pK1 + pK2) of 
these high pKa values, and the sum (9.1) of the low pKa 
values of 4.2 and 4.9 proposed by others [3,17-20], with 
which our high pKa values were compared.
It should thus now be clear that such high pKa values not 
only acceptably explain the experimental findings on the 
effects of pH on the properties and interactions of UCB, but 
that the often quoted low pKa values [3,17-20], are incom-
patible with the experimental data. The implications are not 
trivial, since they invalidate older, but still widely held, 
interpretations and modeling of the binding and cytotoxic-
ity of UCB [43-47] that were based on the assumptions that 
pKa values were below 5.0 and that B= was, therefore the 
dominant species of unbound UCB in the physiological pH 
range (Table 1). More recent reviews are available [1,48,49] 
that are based on the realistic pKa values above 8.0, and the 
consequent predominance of H2B among the unbound UCB 
species at physiological pH values (Figure 1).
List of Abbreviations Used
UCB: unconjugated bilirubin; H2B: UCB diacid; HB-: UCB 
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tive fractions of the unbound monomeric UCB species; F: 
[UCB]bound/[UCB]total; Bf: unbound (free) UCB concentra-
tion; R: the UCB saturation ratio = Bf/estimated solubility 
of UCB at a given pH; K: distribution ratio = mols bound/
mols unbound (free); PC: phosphatidylcholine; c.m.c., criti-
cal micellar concentration; C12M: dodecylmaltoside; C8M: 
octylmaltoside; C8G: octylglucoside; β-CDx: β-cyclodex-
trin.
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